NewEdge Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88K | Sell |
1,199
-3,337
| -74% | -$245K | ﹤0.01% | 2464 |
|
|
2025
Q1 | $518K | Buy |
+4,536
| New | +$518K | ﹤0.01% | 1568 |
|
|
2024
Q3 | – | Sell |
-562
| Closed | -$18.3K | – | 3839 |
|
|
2024
Q2 | $18.3K | Buy |
+562
| New | +$18.3K | ﹤0.01% | 2654 |
|
|
2024
Q1 | – | Sell |
-1,178
| Closed | -$38.3K | – | 3849 |
|
|
2023
Q4 | $38.3K | Sell |
1,178
-110
| -9% | -$3.57K | ﹤0.01% | 2314 |
|
|
2023
Q3 | $35.1K | Sell |
1,288
-33
| -2% | -$899 | ﹤0.01% | 2210 |
|
|
2023
Q2 | $29.4K | Sell |
1,321
-140
| -10% | -$3.12K | ﹤0.01% | 2268 |
|
|
2023
Q1 | $31.6K | Sell |
1,461
-7,319
| -83% | -$159K | ﹤0.01% | 2182 |
|
|
2022
Q4 | $138K | Sell |
8,780
-35,102
| -80% | -$552K | ﹤0.01% | 1315 |
|
|
2022
Q3 | $1.13M | Buy |
43,882
+9,145
| +26% | +$234K | 0.02% | 608 |
|
|
2022
Q2 | $826K | Sell |
34,737
-2,287
| -6% | -$54.4K | 0.01% | 755 |
|
|
2022
Q1 | $833K | Buy |
+37,024
| New | +$833K | 0.01% | 694 |
|